RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Drug-Related Side Effects and Adverse Reactions
Accession: DOID:9006810
browse the term
Definition: Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Synonyms: exact_synonym: Adverse Drug Reaction; Adverse Drug Reactions; Drug Side Effect; Drug Side Effects; Drug Toxicities; adverse drug event; adverse drug events; drug toxicity; side effects of drugs
narrow_synonym: antidepressant-induced dizziness
related_synonym: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to
primary_id: MESH:D064420
xref: EFO:0006321 ; EFO:0020003
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 PMID:28193520 PMID:32387182 More...
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18256692
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc12
ATP binding cassette subfamily C member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr19:20,549,298...20,621,991
Ensembl chr19:20,549,405...20,620,734
G
Abcc2
ATP binding cassette subfamily C member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc4
ATP binding cassette subfamily C member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23222202
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21064136 PMID:32387182
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ache
acetylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27083141
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15641640
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15641640
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Afm
afamin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
G
Ahsg
alpha-2-HS-glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24361871 PMID:28885000
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Ambp
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
G
Apob
apolipoprotein B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31186542
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
G
Arid5b
AT-rich interaction domain 5B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24712521
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
G
Ass1
argininosuccinate synthase 1
IEP
protein:increased expression:plasma (rat)
RGD
PMID:20544730
RGD:4140449
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16947783
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
G
B2m
beta-2 microglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3111302
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30552955
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
associated with colon cancer
RGD
PMID:22020760
RGD:15097511
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl4
C-C motif chemokine ligand 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Cda
cytidine deaminase
ISO
DNA:SNP:cds:rs1048977|rs12726436|rs2072671 (human)
RGD
PMID:28347776
RGD:152995291
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
G
Ces2h
carboxylesterase 2H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19931604
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Clu
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24361871 PMID:28885000
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Commd1
copper metabolism domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23583003
NCBI chr14:96,880,463...96,984,494
Ensembl chr14:96,880,463...96,984,501
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Csf2
colony stimulating factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7960606
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:7692001 PMID:27737899 PMID:31557154
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Cst3
cystatin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10445756
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11740344 PMID:19925388 PMID:23104259
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27736846
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23609392
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18990727
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dhfr
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21064136
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Dip2b
disco-interacting protein 2 homolog B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 7:131,174,575...131,350,417
Ensembl chr 7:131,174,567...131,349,092
G
Dpyd
dihydropyrimidine dehydrogenase
ISO
DNA:SNP:cds:rs12119882 (human)
RGD
PMID:28347776
RGD:152995291
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Enosf1
enolase superfamily member 1
ISO
DNA:SNP:cds:rs699517 (human)
RGD
PMID:28347776
RGD:152995291
NCBI chr 9:113,275,267...113,314,842
G
Epha7
Eph receptor A7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30357299
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
G
Ephx2
epoxide hydrolase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26165641
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human) associated with Leukemia, Myeloid, Acute
RGD
PMID:25495407 PMID:17197435
RGD:11252168 , RGD:11252178
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
treatment
ISO
DNA:SNP: :p.K751Q (rs13181) (human) associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human)
RGD
PMID:15339847 PMID:17197435
RGD:11252202 , RGD:11252178
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
G
Fga
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15805072
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
G
Gata4
GATA binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31190750
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
G
Gata6
GATA binding protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31190750
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Gc
GC, vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gsta1
glutathione S-transferase alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15805072 PMID:24361871 PMID:28885000
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hmgb1
high mobility group box 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27474498
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18227147
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Homer1
homer scaffold protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24126708
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hpx
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Hspb6
heat shock protein family B (small) member 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18948619
NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:85,806,146...85,809,071
G
Htr2b
5-hydroxytryptamine receptor 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16863450
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20064577
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15805072
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
IgG-2a
gamma-2a immunoglobulin heavy chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il3
interleukin 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8202718
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1720698
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ltbr
lymphotoxin beta receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 4:158,108,884...158,115,339
Ensembl chr 4:158,108,886...158,121,539
G
Mapk14
mitogen activated protein kinase 14
susceptibility
ISO
associated with lung non-small cell carcinoma;DNA:SNP:3' utr, intron: (rs3804451) (human)
RGD
PMID:26993769
RGD:151665351
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mocos
molybdenum cofactor sulfurase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29935280
NCBI chr18:15,931,659...15,977,415
Ensembl chr18:15,931,654...15,977,187
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
ISO
ClinVar Annotator: match by term: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to
ClinVar
PMID:9243242 PMID:17101920
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 PMID:19159907 PMID:19391036 PMID:19821069 PMID:21064136 PMID:25007187 PMID:26077125 More...
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15753437 PMID:19159907
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21064136
NCBI chr 1:34,866,991...34,899,425
Ensembl chr 1:34,867,089...34,899,425
G
Mug1
murinoglobulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
G
Nat1
N-acetyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11505221
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nat2
N-acetyltransferase 2
susceptibility
ISO
DNA:polymorphism: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17377643 PMID:17502830 PMID:12786839
RGD:8552667
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20605904
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29802709
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nt5c2
5'-nucleotidase, cytosolic II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr 1:245,770,993...245,896,925
Ensembl chr 1:245,772,277...245,897,913
G
Orm1
orosomucoid 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Peli1
pellino E3 ubiquitin protein ligase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
G
Plg
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Plk2
polo-like kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12897130
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19683050
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10698006
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ren
renin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8723173
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
G
Rup2
urinary protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 8:35,336,764...35,340,345
Ensembl chr 8:35,336,764...35,489,103
G
Serpina1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Shmt1
serine hydroxymethyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21064136
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Slc19a1
solute carrier family 19 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21064136
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
G
Slc22a7
solute carrier family 22 member 7
ISO
DNA:SNP:cds:rs2270860|rs4149178 (human)
RGD
PMID:28347776
RGD:152995291
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc34a2
solute carrier family 34 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15805072
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slco2a1
solute carrier organic anion transporter family, member 2a1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15805072
NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15805072
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tcn2
transcobalamin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15753437
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27474498
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tlr1
toll-like receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr2
toll-like receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103 PMID:31557154
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31557154
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Top1
DNA topoisomerase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19931604
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9369336
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ttr
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Txn1
thioredoxin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11462148
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Tyms
thymidylate synthetase
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:cds:rs2853741 (human)
CTD RGD
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 PMID:28347776
RGD:152995291
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19931604
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Umps
uridine monophosphate synthetase
ISO
DNA:SNP:cds:rs2279199|rs4678145 (human)
RGD
PMID:28347776
RGD:152995291
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068094
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vkorc1
vitamin K epoxide reductase complex, subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26445138
NCBI chr 1:182,502,491...182,505,012
Ensembl chr 1:182,500,844...182,505,008
G
Abcb1a
ATP binding cassette subfamily B member 1A
susceptibility
ISO
DNA:missense mutation:cds:p.G671V (human)
RGD
PMID:16330681
RGD:11041175
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Acvr2b
activin A receptor type 2B
treatment
ISO
human construct in mouse model
RGD
PMID:30765322
RGD:329849112
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Capn2
calpain 2
treatment
IEP
RGD
PMID:25634181
RGD:13792617
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human)
RGD
PMID:24284041
RGD:11252190
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
G
Cacng6
calcium voltage-gated channel auxiliary subunit gamma 6
susceptibility
ISO
DNA:SNP,haplotype:rs192808(human)
RGD
PMID:20860846
RGD:13524562
NCBI chr 1:65,732,910...65,747,377
Ensembl chr 1:65,732,632...65,747,341
G
Ccr3
C-C motif chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20485159 PMID:20022477
RGD:4145619
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481 PMID:17641958 PMID:20485159
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:15970796
RGD:5144000
NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136
G
Fancc
FA complementation group C
ISO
DNA:haplotype::rs4647416(human)
RGD
PMID:21670957
RGD:11045795
NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376
G
Il4
interleukin 4
susceptibility
ISO
DNA:SNPs:promoter,5'UTR,intron:multiple
RGD
PMID:20921925
RGD:11528633
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
G
Ms4a2
membrane spanning 4-domains A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Postn
periostin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Ptgdr2
prostaglandin D2 receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr 1:207,585,088...207,590,275
Ensembl chr 1:207,587,917...207,589,213
G
Ptger2
prostaglandin E receptor 2
ISO
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:15496426 PMID:16502481
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Ptgir
prostaglandin I2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr 1:77,579,596...77,581,979
Ensembl chr 1:77,579,596...77,581,979
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
protein:increased expression:mast cell CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:9487340
RGD:5143936
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
RGD
PMID:25975240
RGD:11074090
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
RGD
PMID:25975240
RGD:11074090
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
RGD
PMID:25975240
RGD:11074090
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Tap2
transporter 2, ATP binding cassette subfamily B member
ISO
RGD
PMID:21796142
RGD:5147839
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tbx21
T-box transcription factor 21
ISO
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:15806396 PMID:16502481
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
G
Tbxa2r
thromboxane A2 receptor
susceptibility
ISO
DNA:polymorphism: :795T>C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16502481 PMID:20485159 PMID:15898979
RGD:11059537
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Alox15
arachidonate 15-lipoxygenase
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:17959182 PMID:21558275 PMID:30643255
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
Ptger2
prostaglandin E receptor 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Tbx21
T-box transcription factor 21
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:25741868
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
G
Acacb
acetyl-CoA carboxylase beta
IEP
mRNA, protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33676887
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26145887
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bmp2
bone morphogenetic protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29800642
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35792220
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cpt1a
carnitine palmitoyltransferase 1A
IEP
mRNA, protein:decreased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Csf1
colony stimulating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fto
FTO, alpha-ketoglutarate dependent dioxygenase
IDA
DNA:hypermethylation:promoter
RGD
PMID:35462195
RGD:329951017
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
G
Hbegf
heparin-binding EGF-like growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Il1b
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34648132
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
G
Mir143
microRNA 143
ameliorates
ISO
RGD
PMID:32170053
RGD:155883163
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Mir208a
microRNA 208a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26454886
NCBI chr15:28,425,570...28,425,652
G
Mlycd
malonyl-CoA decarboxylase
IEP
protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
G
Nos3
nitric oxide synthase 3
treatment
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human)
RGD
PMID:26345518
RGD:11533645
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nppb
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
IEP
protein:decreased expression:serum, heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Rac1
Rac family small GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28710503
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Rarg
retinoic acid receptor, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237429
NCBI chr 7:133,367,833...133,390,301
Ensembl chr 7:133,367,833...133,390,177
G
Rnf10
ring finger protein 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36740146
NCBI chr12:41,341,708...41,375,505
Ensembl chr12:41,341,717...41,375,504
G
Sirt6
sirtuin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34713381
NCBI chr 7:8,082,312...8,087,776
Ensembl chr 7:8,082,364...8,098,914
G
Tlr2
toll-like receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987 PMID:32068018
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30009776 PMID:34713381
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Aass
aminoadipate-semialdehyde synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Abcb11
ATP binding cassette subfamily B member 11
severity
ISO
DNA:SNP: :rs2287616(human)
RGD
PMID:27293027
RGD:14402413
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
severity susceptibility
ISO
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832
RGD:11041130 , RGD:14700895
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27193730
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc1
ATP binding cassette subfamily C member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human)
CTD RGD
PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354
RGD:14700814 , RGD:14700812
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abi1
abl-interactor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
G
Ace
angiotensin I converting enzyme
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:25143335
RGD:25671447
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Acox3
acyl-CoA oxidase 3, pristanoyl
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:75,133,986...75,176,767
Ensembl chr14:75,094,676...75,176,205
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Actb
actin, beta
IEP ISO
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25231249 PMID:22563491
RGD:9587759
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
G
Actr3
actin related protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
G
Ada
adenosine deaminase
IEP
protein:increased expression:liver
RGD
PMID:21161045
RGD:5128859
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
Adam8
ADAM metallopeptidase domain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24646716
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20709802
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adipor2
adiponectin receptor 2
severity
IEP
associated with obesity, LPS;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adora2b
adenosine A2B receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29499335
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahr
aryl hydrocarbon receptor
ISO IEP
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat)
CTD RGD
PMID:21890736 PMID:34848246 PMID:28959666
RGD:401794432
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25743375
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Ak4
adenylate kinase 4
IEP
protein:increased expression:liver (rat)
RGD
PMID:16538043
RGD:2301096
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akr1a1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32805337 PMID:29763686
RGD:27226688
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Alb
albumin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18779383 PMID:22310181 PMID:27567545
RGD:14694844
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1l2
aldehyde dehydrogenase 1 family, member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
G
Aldh2
aldehyde dehydrogenase 2 family member
severity susceptibility
IEP ISO
protein:increased expression:liver DNA:deletion:exon 3 (mouse)
RGD
PMID:21138988 PMID:30121625 PMID:24492981
RGD:7241599 , RGD:15036810 , RGD:14975148
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh9a1
aldehyde dehydrogenase 9 family, member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
G
Aldob
aldolase, fructose-bisphosphate B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Ambp
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18779383
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Anxa6
annexin A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
G
Apoa1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Apoh
apolipoprotein H
IEP ISO
mRNA:increased expression:plasma: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16099942 PMID:23288050
RGD:10054107
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
G
Arg1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22872058
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20935161
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Atg5
autophagy related 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22491424
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atoh8
atonal bHLH transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
G
Atp6v1d
ATPase H+ transporting V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303
G
Bad
BCL2-associated agonist of cell death
treatment
IDA
RGD
PMID:25447754
RGD:10053709
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17906064
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Blvrb
biliverdin reductase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bmal1
basic helix-loop-helix ARNT like 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36602574
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:96,865,634...96,893,506
Ensembl chr13:96,868,580...96,893,503
G
Brd4
bromodomain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
G
Btd
biotinidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15469856
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cabp1
calcium binding protein 1
IEP
protein:increased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
G
Cadps2
calcium dependent secretion activator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 4:51,780,415...52,309,641
Ensembl chr 4:51,781,053...52,309,829
G
Canx
calnexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
G
Car3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:25231249
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:25447754
RGD:10053709
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cast
calpastatin
IEP
RGD
PMID:16871587
RGD:5683869
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
ISO IEP
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:20623750 PMID:25231249 PMID:21138988
RGD:7241599
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccdc80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:21813474 PMID:30663942
RGD:14995466 , RGD:14995458
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Ccr5
C-C motif chemokine receptor 5
susceptibility
ISO
acetaminophen
RGD
PMID:24770590
RGD:14401733
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cct3
chaperonin containing TCP1 subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757
G
Cct5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
G
Cdc25b
cell division cycle 25B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
G
Cela1
chymotrypsin like elastase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
G
Cfap20
cilia and flagella associated protein 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:9,608,867...9,622,558
Ensembl chr19:9,608,859...9,622,558
G
Cfh
complement factor H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Chrm3
cholinergic receptor, muscarinic 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Ckb
creatine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
G
Clu
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Col14a1
collagen type XIV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
G
Col3a1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16679477
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Comt
catechol-O-methyltransferase
IEP
protein:decreased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Coq9
coenzyme Q9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:10,166,948...10,179,976
Ensembl chr19:10,166,951...10,179,949
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpb2
carboxypeptidase B2
IEP
mRNA,protein:increased expression,increased activity:liver,plasma
RGD
PMID:19386599
RGD:7243112
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
G
Cps1
carbamoyl-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Cpt1a
carnitine palmitoyltransferase 1A
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20005281
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19679878
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctse
cathepsin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16118408
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11739529
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16118408
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
ISO
mRNA, protein:decreased expression:kidney (mouse)
RGD
PMID:26476181
RGD:25671412
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043 PMID:33814510
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14971821 PMID:21741958 PMID:25226513 PMID:28762043 PMID:33814510
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12963435 PMID:28762043
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
DNA:hypermethylation:promoter
RGD
PMID:27490558
RGD:14700879
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter associated with Endotoxemia
CTD RGD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 PMID:27490558 PMID:27324775 PMID:29404441 PMID:25681370 More...
RGD:14700901 , RGD:14700879 , RGD:14700878 , RGD:14700873 , RGD:14700872
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25448281
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dbt
dihydrolipoamide branched chain transacylase E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
G
Ddb1
damage-specific DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:207,252,890...207,278,685
Ensembl chr 1:207,252,890...207,278,676
G
Dgat2
diacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dhfr
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19648163
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Dhrs7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Dlat
dihydrolipoamide S-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:50,979,151...51,004,435
Ensembl chr 8:50,978,051...51,004,479
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
G
Dsc2
desmocollin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
G
E2f1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Echdc1
ethylmalonyl-CoA decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319
G
Echs1
enoyl-CoA hydratase, short chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25411909
NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
G
Endog
endonuclease G
IEP
protein:decreased expression:mitochondrion:
RGD
PMID:22509279
RGD:9685364
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
G
Eng
endoglin
IEP
protein:increased expression:liver (rat)
RGD
PMID:21146604
RGD:7257529
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:25231249
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
IEP
protein:increased activity:serum:
RGD
PMID:17850827
RGD:9685426
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Erlec1
endoplasmic reticulum lectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:104,655,745...104,693,508
Ensembl chr14:104,655,673...104,693,480
G
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
F13a1
coagulation factor XIII A1 chain
ISO
RGD
PMID:22019897
RGD:11041813
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
G
F2rl3
F2R like thrombin or trypsin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr16:17,117,441...17,119,434
Ensembl chr16:17,117,441...17,119,472
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407844
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fadd
Fas associated via death domain
treatment
IEP
RGD
PMID:26062544 PMID:25447754
RGD:11341803 , RGD:10053709
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
G
Fads1
fatty acid desaturase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
G
Fads2
fatty acid desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
G
Fas
Fas cell surface death receptor
IEP
protein:increased expression:liver (rat)
RGD
PMID:16831245
RGD:8662853
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fasn
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fcmr
Fc mu receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:42,337,363...42,351,706
Ensembl chr13:42,337,414...42,351,653
G
Fga
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgf21
fibroblast growth factor 21
severity
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:29883717
RGD:15045603
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21135413
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fmo3
flavin containing dimethylaniline monoxygenase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24973094
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
G
Ftl1
ferritin light chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:28189721
RGD:14695531
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
IEP
RGD
PMID:21864513
RGD:10449168
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Ganab
glucosidase II alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:205,793,910...205,813,704
Ensembl chr 1:205,793,895...205,813,695
G
Gc
GC, vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gclc
glutamate-cysteine ligase, catalytic subunit
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19481141 PMID:17573345
RGD:10402383
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gdi1
GDP dissociation inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
G
Gfer
growth factor, augmenter of liver regeneration
treatment
ISO IDA
RGD
PMID:22033404 PMID:15968720
RGD:9685722 , RGD:9685727
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Ggh
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21219404
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
G
Ggt1
gamma-glutamyltransferase 1
IEP
RGD
PMID:10934156
RGD:14701049
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Glud1
glutamate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33483742
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
G
Got1
glutamic-oxaloacetic transaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Gpt
glutamic--pyruvic transaminase
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum:
CTD RGD
PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 PMID:21772750 PMID:28487901 More...
RGD:14975249 , RGD:14975249 , RGD:14975168 , RGD:14975166 , RGD:14975162
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpt2
glutamic--pyruvic transaminase 2
IEP ISO
protein:increased expression, activity:serum:
RGD
PMID:19085960 PMID:19085960
RGD:14975249 , RGD:14975249
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Grk4
G protein-coupled receptor kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:75,998,554...76,080,808
Ensembl chr14:76,006,218...76,080,693
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gsr
glutathione-disulfide reductase
treatment
IEP ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663
RGD:7257532 , RGD:10401878
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28412881
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta4
glutathione S-transferase alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gstm1
glutathione S-transferase mu 1
no_association
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 PMID:29523098 PMID:21138988 More...
RGD:14700970 , RGD:14700959 , RGD:14700941 , RGD:14700937 , RGD:7241599
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
G
Gstm5
glutathione S-transferase, mu 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25743375
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Gsto1
glutathione S-transferase omega 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:25226513
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18397238 PMID:18666253 PMID:25226513
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
H19
H19 imprinted maternally expressed transcript
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
H2ax
H2A.X variant histone
treatment
IDA
RGD
PMID:23265463
RGD:8693741
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hacl1
2-hydroxyacyl-CoA lyase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hamp
hepcidin antimicrobial peptide
IEP
mRNA:increased expression:hepatocyte
RGD
PMID:24373749
RGD:11041724
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hao2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hba-a1
hemoglobin alpha, adult chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
G
Hmgb1
high mobility group box 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:29091898
RGD:15090820
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmox1
heme oxygenase 1
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898
RGD:10762620 , RGD:15090820
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpd
4-hydroxyphenylpyruvate dioxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:22872058
NCBI chr12:33,381,397...33,392,750
Ensembl chr12:33,381,231...33,392,766
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hpx
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Hrh2
histamine receptor H 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926047
NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631
G
Hspa5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa8
heat shock protein family A (Hsp70) member 8
IEP
protein:altered localization:liver (rat)
RGD
PMID:12376827
RGD:10059389
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Icam1
intercellular adhesion molecule 1
treatment
IEP
RGD
PMID:29091898
RGD:15090820
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:31121248
RGD:14985250
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ido2
indoleamine 2,3-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12153990 PMID:21245496 PMID:30013034
RGD:14975100
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23639586 PMID:25226513
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il11
interleukin 11
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11421492
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19633216 PMID:24949944
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19164858
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8218930
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
treatment
IDA IEP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 PMID:31077717 PMID:29278859 More...
RGD:7204421 , RGD:15090820 , RGD:15036799 , RGD:14975281 , RGD:13793380
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
G
Il22
interleukin 22
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15122762 PMID:16212920 PMID:23375450
NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:53,801,206...53,806,186
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21094227 PMID:21735453 PMID:22107450
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
treatment
ISO IEP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:7532385 PMID:15763341 PMID:29091898
RGD:15090820
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Immt
inner membrane mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Keap1
Kelch-like ECH-associated protein 1
ISO
RGD
PMID:18417483
RGD:6893370
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12594235
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:30685357
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Krt18
keratin 18
ISO
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:33483742 PMID:17340120
RGD:18337498
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Lap3
leucine aminopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:65,608,375...65,627,359
Ensembl chr14:65,608,376...65,627,359
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lcat
lecithin cholesterol acyltransferase
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:20623750
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lgals3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22461450
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lipc
lipase C, hepatic type
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
G
Lpl
lipoprotein lipase
treatment
IEP
RGD
PMID:27071702
RGD:13794380
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrat
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
G
Ltb4r
leukotriene B4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28487374
NCBI chr15:29,263,199...29,265,716
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18700144
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Mat1a
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
G
Mccc1
methylcrotonyl-CoA carboxylase subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:118,799,150...118,851,222
G
Mdh1
malate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Med1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16109766
NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
G
Mir100
microRNA 100
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:41,901,225...41,901,304
Ensembl chr 8:41,901,225...41,901,304
G
Mir103a1
microRNA 103a-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr10:20,244,412...20,244,497
Ensembl chr10:20,244,412...20,244,497
G
Mir106b
microRNA 106b
IEP IDA
miRNA:decreased expression:liver (rat) DNA:hypermethylation:promoter
RGD
PMID:29554950 PMID:29554950
RGD:15042854 , RGD:15042854
NCBI chr12:17,043,344...17,043,425
Ensembl chr12:17,043,344...17,043,425
G
Mir107
microRNA 107
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
G
Mir10b
microRNA 10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 3:59,628,438...59,628,546
Ensembl chr 3:59,628,438...59,628,546
G
Mir122
microRNA 122
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 PMID:28545106 PMID:28844483 PMID:33483742 More...
NCBI chr18:58,758,703...58,758,787
G
Mir1249
microRNA 1249
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:116,075,593...116,075,712
Ensembl chr 7:116,075,593...116,075,712
G
Mir125b1
microRNA 125b-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:41,952,966...41,953,052
Ensembl chr 8:41,952,966...41,953,052
G
Mir125b2
microRNA 125b-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:16,245,620...16,245,707
G
Mir1306
microRNA 1306
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:82,709,651...82,709,723
Ensembl chr11:82,709,637...82,709,719
G
Mir130a
microRNA 130a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
G
Mir130b
microRNA 130b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:83,880,163...83,880,244
Ensembl chr11:83,880,163...83,880,244
G
Mir132
microRNA 132
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
G
Mir141
microRNA 141
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
G
Mir142
microRNA 142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:72,557,864...72,557,950
Ensembl chr10:72,557,857...72,557,967
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Mir148a
microRNA 148a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
G
Mir150
microRNA 150
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:95,605,024...95,605,108
G
Mir151b
microRNA 151b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:105,172,377...105,172,496
Ensembl chr 7:105,172,377...105,172,496
G
Mir152
microRNA 152
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
G
Mir155
microRNA 155
treatment
ISO
RGD
PMID:29420849 PMID:26867493 PMID:27673475
RGD:21409750 , RGD:25671474 , RGD:25671463
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir17
microRNA 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
G
Mir181c
microRNA 181c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
G
Mir188
microRNA 188
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:15,247,715...15,247,794
Ensembl chr X:15,247,715...15,247,794
G
Mir18a
microRNA 18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
G
Mir191
microRNA 191
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:109,264,098...109,264,188
G
Mir192
microRNA 192
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106
NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055
G
Mir193a
microRNA 193a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir193b
microRNA 193b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
G
Mir194-1
microRNA 194-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28844483
NCBI chr13:96,851,166...96,851,248
Ensembl chr13:96,851,166...96,851,248
G
Mir19a
microRNA 19a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
G
Mir1b
microRNA 1b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr 3:167,487,117...167,487,201
Ensembl chr 3:167,487,117...167,487,201
G
Mir200c
microRNA 200c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 4:157,523,679...157,523,747
G
Mir21
microRNA 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir210
microRNA 210
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir217
microRNA 217
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr14:102,531,505...102,531,609
Ensembl chr14:102,531,505...102,531,609
G
Mir22
microRNA 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
G
Mir221
microRNA 221
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:3,429,465...3,429,573
Ensembl chr X:3,429,465...3,429,573
G
Mir222
microRNA 222
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
G
Mir223
microRNA 223
ISO
RNA:increased expression:serum,liver
RGD
PMID:28646120
RGD:21408574
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mir23a
microRNA 23a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr19:23,954,997...23,955,071
Ensembl chr19:23,954,997...23,955,071
G
Mir23b
microRNA 23b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mir27b
microRNA 27b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
G
Mir29b2
microRNA 29b-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr13:106,570,371...106,570,451
Ensembl chr13:106,570,367...106,570,456
G
Mir301a
microRNA 301a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:71,925,336...71,925,435
Ensembl chr10:71,925,336...71,925,435
G
Mir30a
microRNA 30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:25359176 PMID:28545106
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
G
Mir30b
microRNA 30b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:100,132,589...100,132,675
Ensembl chr 7:100,132,589...100,132,675
G
Mir30c1
microRNA 30c-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 5:134,349,237...134,349,325
Ensembl chr 5:134,349,237...134,349,325
G
Mir320a
microRNA 320a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30125006
NCBI chr15:45,516,392...45,516,473
Ensembl chr15:45,516,392...45,516,473
G
Mir328
microRNA 328
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr19:33,184,766...33,184,849
Ensembl chr19:33,184,766...33,184,849
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 6:128,538,903...128,538,999
Ensembl chr 6:128,538,902...128,538,998
G
Mir342
microRNA 342
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:127,565,269...127,565,367
Ensembl chr 6:127,565,269...127,565,367
G
Mir345
microRNA 345
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:127,754,027...127,754,122
G
Mir34a
microRNA 34a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mir34c
microRNA 34c
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
G
Mir3545
microRNA 3545
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32659284
NCBI chr 6:131,199,542...131,199,656
Ensembl chr 6:131,199,542...131,199,656
G
Mir361
microRNA 361
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:78,246,206...78,246,275
Ensembl chr X:78,246,206...78,246,275
G
Mir410
microRNA 410
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 6:128,758,358...128,758,433
Ensembl chr 6:128,758,354...128,758,434
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
G
Mir455
microRNA 455
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:76,689,313...76,689,390
Ensembl chr 5:76,689,313...76,689,390
G
Mir484
microRNA 484
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
G
Mir497
microRNA 497
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
G
Mir499a
microRNA 499a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:144,110,469...144,110,533
Ensembl chr 3:144,110,469...144,110,533
G
Mir503
microRNA 503
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:132,806,303...132,806,373
Ensembl chr X:132,806,303...132,806,373
G
Mir532
microRNA 532
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:15,247,315...15,247,393
Ensembl chr X:15,247,315...15,247,393
G
Mir592
microRNA 592
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr 4:56,505,280...56,505,375
Ensembl chr 4:56,505,280...56,505,375
G
Mir764
microRNA 764
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:110,678,597...110,678,704
Ensembl chr X:110,678,597...110,678,704
G
Mir877
microRNA 877
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27713024
NCBI chr20:2,811,476...2,811,560
Ensembl chr20:2,811,476...2,811,560
G
Mir93
microRNA 93
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:17,043,135...17,043,221
Ensembl chr12:17,043,135...17,043,221
G
Mir99a
microRNA 99a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:16,200,443...16,200,523
Ensembl chr11:16,200,443...16,200,523
G
Mirlet7b
microRNA let-7b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30125006
NCBI chr 7:116,804,186...116,804,270
Ensembl chr 7:116,804,186...116,804,270
G
Mirlet7c1
microRNA let-7c-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:16,201,163...16,201,256
Ensembl chr11:16,201,158...16,201,265
G
Mirlet7d
microRNA let-7d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:16,115,893...16,115,990
Ensembl chr17:16,115,893...16,115,990
G
Mirlet7g
microRNA let-7g
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:106,822,293...106,822,380
Ensembl chr 8:106,822,280...106,822,388
G
Mirlet7i
microRNA let-7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:58,642,485...58,642,569
Ensembl chr 7:58,642,480...58,642,571
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15763341
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mst1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:108,767,886...108,773,425
Ensembl chr 8:108,768,839...108,773,416
G
Mst1r
macrophage stimulating 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22575169
NCBI chr 8:108,596,100...108,611,441
Ensembl chr 8:108,597,299...108,612,455
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
IEP
mRNA:decreased expression:blood
RGD
PMID:20130021
RGD:8657129
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Mthfr
methylenetetrahydrofolate reductase
treatment
ISO
CTD Direct Evidence: marker/mechanism associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD RGD
PMID:18551038 PMID:19648163 PMID:30545275
RGD:14696733
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Mtpn
myotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:64,159,273...64,186,686
Ensembl chr 4:64,157,641...64,186,724
G
Mug2
murinoglobulin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
G
Myd88
MYD88, innate immune signal transduction adaptor
ameliorates
ISO
RGD
PMID:17615358
RGD:150521532
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nat2
N-acetyltransferase 2
treatment
ISO
associated with Tuberculosis;DNA:haplotype: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865 PMID:18023090
RGD:8552665
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:76,876,646...76,883,824
Ensembl chr 3:76,876,646...76,883,824
G
Nfatc4
nuclear factor of activated T-cells 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34192554
NCBI chr15:29,286,998...29,314,610
Ensembl chr15:29,305,535...29,314,610
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO IEP
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) CTD Direct Evidence: therapeutic
CTD RGD
PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777 PMID:18417483 PMID:31889292 PMID:31927046 PMID:32066295 PMID:31972209 PMID:29091898 More...
RGD:6893370 , RGD:21201308 , RGD:21201305 , RGD:21201283 , RGD:21201280 , RGD:15090820
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
treatment susceptibility
IEP ISO
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human)
RGD
PMID:29091898 PMID:31490979
RGD:15090820 , RGD:40902984
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfxl1
nuclear transcription factor, X-box binding-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:35,626,086...35,667,505
Ensembl chr14:35,626,066...35,667,498
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Notch1
notch receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30394310
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nox4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
IDA IEP ISO
RGD
PMID:28522909 PMID:29091898 PMID:28472605
RGD:13439737 , RGD:15090820 , RGD:13439739
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29943110
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
treatment
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17256725
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
treatment severity
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver (rat) protein:decreased expression:liver (rat)
CTD RGD
PMID:12875239 PMID:29091898 PMID:28827769 PMID:30068870 PMID:22711662 PMID:20573685 More...
RGD:15090820 , RGD:15045609 , RGD:15042870 , RGD:14701036 , RGD:14701035
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism|therapeutic associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD RGD
PMID:19797606 PMID:28058446 PMID:31490979
RGD:40902984
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14742670 PMID:25656644 PMID:28058446
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:124,008,282...124,022,521
Ensembl chr 1:124,009,181...124,022,031
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Nrep
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Ntn1
netrin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chr20:31,811,817...31,838,562
Ensembl chr20:31,811,817...31,838,561
G
Obp3
alpha-2u globulin PGCL4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
G
Ociad1
OCIA domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:34,897,851...34,915,291
Ensembl chr14:34,897,847...34,915,286
G
Ogdh
oxoglutarate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Olr59
olfactory receptor 59
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
G
P4hb
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pah
phenylalanine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
G
Pan2
poly(A) specific ribonuclease subunit PAN2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 7:729,146...747,744
Ensembl chr 7:729,562...747,744
G
Panx1
Pannexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29246445
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
G
Park7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
G
Pc
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcolce
procollagen C-endopeptidase enhancer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
Pcyt1a
phosphate cytidylyltransferase 1A, choline
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:68,313,860...68,357,828
Ensembl chr11:68,313,882...68,357,357
G
Pdk4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21182459 PMID:31809757
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pdlim5
PDZ and LIM domain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
G
Pex11a
peroxisomal biogenesis factor 11 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
G
Pgm1
phosphoglucomutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plg
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Pls3
plastin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Pnp
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Pnrc1
proline-rich nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
G
Polg
DNA polymerase gamma, catalytic subunit
susceptibility no_association
ISO IAGP
CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
CTD RGD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931
RGD:15039302 , RGD:15039297
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
G
Polr2g
RNA polymerase II subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:205,689,160...205,692,537
Ensembl chr 1:205,689,160...205,692,686
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24385052 PMID:21262334
RGD:5509941
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:26599535
RGD:11554658
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Pptc7
protein phosphatase targeting COQ7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:34,249,963...34,288,339
Ensembl chr12:34,249,977...34,288,339
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
treatment
IEP
RGD
PMID:29091898
RGD:15090820
NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978
G
Prkcd
protein kinase C, delta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30393195
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21224054
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Ptf1a
pancreas associated transcription factor 1a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21182459
NCBI chr17:82,051,281...82,053,135
Ensembl chr17:82,051,281...82,053,135
G
Ptges2
prostaglandin E synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31444509
NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
ISO IEP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:11743745 PMID:29091898
RGD:15090820
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pum1
pumilio RNA-binding family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:142,836,933...142,954,331
Ensembl chr 5:142,837,127...142,954,039
G
Pygl
glycogen phosphorylase L
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:25231249 PMID:25336395
RGD:21079733
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:15,857,704...15,940,757
Ensembl chr 2:15,857,980...15,940,854
G
Rbp1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rdh13
retinol dehydrogenase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr 1:69,373,014...69,401,454
Ensembl chr 1:69,373,113...69,400,908
G
Reep5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Ripk3
receptor-interacting serine-threonine kinase 3
ISO
CTD Direct Evidence: therapeutic protein:increased expression:liver (mouse)
CTD RGD
PMID:26769846 PMID:28205631
RGD:127229945
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphism: :HLA-DQA1*0102(human) associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)
RGD
PMID:20639878 PMID:12359646
RGD:14398844 , RGD:14401573
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DQB1*05(human) DNA:polymorphism, haplotype
CTD RGD
PMID:21570397 PMID:25250564 PMID:26959717
RGD:36174016 , RGD:11573514
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-CE16
RT1 class I, locus CE16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397 PMID:28043905
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
RT1-Db1
RT1 class II, locus Db1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
S100a11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
Scarb1
scavenger receptor class B, member 1
IEP
mRNA:increased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Selenbp1
selenium binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Sema3a
semaphorin 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33290778
NCBI chr 4:21,282,398...21,754,834
Ensembl chr 4:21,287,982...21,494,432
G
Sema4a
semaphorin 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33290778
NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442
G
Senp2
SUMO specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr11:78,981,429...79,018,274
Ensembl chr11:78,981,432...79,018,238
G
Serpina1
serpin family A member 1
susceptibility
IEP ISO
protein:decreased expression:plasma DNA:missense mutation:cds:p.E264V(human)
RGD
PMID:11140575 PMID:20170533
RGD:1643168 , RGD:14695048
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Serpina6
serpin family A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpine1
serpin family E member 1
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:23183238
RGD:14696750
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serping1
serpin family G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sesn2
sestrin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28209544
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sgf29
SAGA complex associated factor 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:181,238,458...181,271,931
Ensembl chr 1:181,238,468...181,274,781
G
Shc1
SHC adaptor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249 PMID:32659284
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
G
Slc10a1
solute carrier family 10 member 1
IEP
mRNA:decreased expression:liver (rat)
RGD
PMID:28827769
RGD:15045609
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc10a7
solute carrier family 10, member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr19:29,183,143...29,407,470
Ensembl chr19:29,183,155...29,407,464
G
Slc13a4
solute carrier family 13 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
G
Slc22a8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc25a29
solute carrier family 25 member 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:127,742,027...127,752,915
Ensembl chr 6:127,742,033...127,752,940
G
Slc7a5
solute carrier family 7 member 5
treatment
IEP
RGD
PMID:9200186
RGD:151357001
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slpi
secretory leukocyte peptidase inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Snx18
sorting nexin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 2:45,232,325...45,258,345
Ensembl chr 2:45,232,325...45,258,345
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:27349771
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
treatment severity susceptibility
ISO IMP
CTD Direct Evidence: marker/mechanism associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) DNA:SNP:cds:p.Val16Ala(human)
CTD RGD
PMID:25226513 PMID:27019981 PMID:19647030 PMID:19332662 PMID:20578157
RGD:11060605 , RGD:26923961 , RGD:26923959 , RGD:26923957
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11529661
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Sord
sorbitol dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12763371
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Sorl1
sortilin related receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Spin2a
spindlin family member 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr X:17,511,018...17,513,001
Ensembl chr X:17,511,022...17,513,001
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Srp72
signal recognition particle 72
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
G
Stat4
signal transducer and activator of transcription 4
severity
ISO
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse)
RGD
PMID:24731448 PMID:23876342
RGD:25671417 , RGD:25671422
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Sting1
stimulator of interferon response cGAMP interactor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
G
Sult1c3
sulfotransferase family 1C member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
G
Sult1e1
sulfotransferase family 1E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
G
Sult2b1
sulfotransferase family 2B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27052460
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Suox
sulfite oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
G
Tagln2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Taldo1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr 1:196,493,634...196,503,965
Ensembl chr 1:196,493,589...196,503,974
G
Tbxa2r
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22206755
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Tctn1
tectonic family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr12:34,309,795...34,347,190
Ensembl chr12:34,309,897...34,342,267
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb1
transforming growth factor, beta 1
treatment
ISO
RGD
PMID:27516150
RGD:14995464
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35357534
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thpo
thrombopoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33122006
Ensembl chr11:80,182,820...80,188,167
G
Tlr4
toll-like receptor 4
disease_progression
IEP
RGD
PMID:17504260
RGD:14697733
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tlr5
toll-like receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30508503
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
G
Tlr9
toll-like receptor 9
severity treatment
ISO
protein:increased expression: blood, neutrophil (human)
RGD
PMID:26457748 PMID:19164858 PMID:23509352
RGD:18337465 , RGD:18337476 , RGD:18337473
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
G
Tmed7
transmembrane p24 trafficking protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr18:39,318,564...39,325,640
Ensembl chr18:39,297,351...39,325,640
G
Tmem117
transmembrane protein 117
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 7:125,757,591...126,219,692
Ensembl chr 7:125,757,591...126,219,690
G
Tmem164
transmembrane protein 164
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:106,288,019...106,448,642
Ensembl chr X:106,289,371...106,448,640
G
Tmem38b
transmembrane protein 38B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:68,460,304...68,496,026
Ensembl chr 5:68,460,304...68,496,025
G
Tnf
tumor necrosis factor
treatment severity
IDA ISO IEP IMP
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum (rat)
CTD RGD
PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:37866487 PMID:15830285 PMID:29091898 PMID:31342809 PMID:14686721 PMID:10801288 PMID:10801287 PMID:9309314 PMID:17070847 PMID:31077717 PMID:11124822 More...
RGD:10450531 , RGD:15090820 , RGD:15036799 , RGD:14995485 , RGD:14995437 , RGD:14995435 , RGD:14995432 , RGD:14995429 , RGD:14975281 , RGD:14696804
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
ISO
RGD
PMID:24569808
RGD:9999438
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Ttr
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Tuba1a
tubulin, alpha 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tubb4b
tubulin, beta 4B class IVb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Uba5
ubiquitin-like modifier activating enzyme 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 8:104,665,241...104,680,915
Ensembl chr 8:104,665,046...104,680,894
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
susceptibility
ISO
DNA:SNP:exon (rs4148323)(human)
RGD
PMID:28900877
RGD:14694824
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Unc93b1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:201,167,388...201,178,343
Ensembl chr 1:201,152,693...201,178,338
G
Usp5
ubiquitin specific peptidase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:157,619,663...157,634,681
Ensembl chr 4:157,619,643...157,634,711
G
Ust5r
integral membrane transport protein UST5r
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:205,210,558...205,286,868
Ensembl chr 1:205,211,034...205,286,718
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25231249 PMID:17784864
RGD:15003197
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vwf
von Willebrand factor
IEP ISO
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28527913 PMID:7531171
RGD:11079232
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Wasl
WASP like actin nucleation promoting factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:53,083,536...53,132,061
Ensembl chr 4:53,083,536...53,132,022
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:haploinsufficiency: : (mouse)
RGD
PMID:21737425
RGD:15036796
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Xylb
xylulokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 8:119,093,466...119,128,858
Ensembl chr 8:119,096,029...119,128,848
G
Zdhhc23
zinc finger DHHC-type palmitoyltransferase 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:56,718,702...56,735,063
Ensembl chr11:56,718,826...56,734,194
G
Abcc2
ATP binding cassette subfamily C member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20216337
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18727619
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19019667
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19019667
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Ccl11
C-C motif chemokine ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14616128
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl24
C-C motif chemokine ligand 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14616128
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16630147
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15970796
NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136
G
Faslg
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19706026
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcer1a
Fc epsilon receptor Ia
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17125826 PMID:20485159
NCBI chr13:85,686,099...85,692,394
Ensembl chr13:85,686,092...85,692,351
G
Fcer1g
Fc epsilon receptor Ig
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18534082 PMID:18595682
NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20485159 PMID:11007341
RGD:5491000
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20485159 PMID:16297214
RGD:5490995
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:11007341
RGD:5491000
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gzmb
granzyme B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19706026
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Hnmt
histamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16538175
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16538175
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19222424 PMID:20485159
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il2
interleukin 2
ISO
RGD
PMID:1549655
RGD:8662975
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15867870 PMID:20485159
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16433794
NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
G
Mln
motilin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16538176
NCBI chr20:5,304,249...5,308,948
Ensembl chr20:5,304,249...5,308,948
G
Ms4a2
membrane spanning 4-domains A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16839402 PMID:18534082 PMID:20485159
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
G
Nat2
N-acetyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159 PMID:20602614 PMID:21572414
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19767079
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Postn
periostin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
G
Ptger3
prostaglandin E receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20587336
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17508966
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
RT1-Db1
RT1 class II, locus Db1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20485159
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Tac1
tachykinin, precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21233199
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tbxas1
thromboxane A synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21449675
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11294926 PMID:20485159
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19652058
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Apoa1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21055120
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoc2
apolipoprotein C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21055120
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
Apoc3
apolipoprotein C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21055120
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Bdnf
brain-derived neurotrophic factor
ISO
mRNA:increased expression:lymph node, ear:
RGD
PMID:19904815
RGD:8657071
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
C4b
complement C4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21055120
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19351467
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
susceptibility treatment
ISO
DNA:SNP: :Rs4244285(human) associated with tuberculosis; DNA.polymorphism, haplotype:cds:p.W212X (human)
RGD
PMID:23551241 PMID:20941486
RGD:11352742 , RGD:124713543
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19351467
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Fcer1a
Fc epsilon receptor Ia
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr13:85,686,099...85,692,394
Ensembl chr13:85,686,092...85,692,351
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31150805
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31150805
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18204966
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31150805
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19351467
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:1371395 PMID:3034372
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18204966
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14723717
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31150805
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphisms:exon:
RGD
PMID:16836882
RGD:8547665
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16502481
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Tac1
tachykinin, precursor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1371395
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31150805
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ttr
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21055120
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
C1qa
complement C1q A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C1qc
complement C1q C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
G
Cfhr1
complement factor H-related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr13:51,395,583...51,410,571
Ensembl chr13:51,369,211...51,410,592
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
ISO
DNA:polymorphism, haplotype: :p.M493T (human)
RGD
PMID:15024131
RGD:8662461
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Il1b
interleukin 1 beta
ISO
DNA:SNP:promoter:-511C>T (rs 16944) (human)
RGD
PMID:23461376
RGD:11051970
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
DNA:SNP:intron:rs2234663 (human)
RGD
PMID:23461376
RGD:11051970
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Orm1
orosomucoid 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Vwf
von Willebrand factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Abat
4-aminobutyrate aminotransferase
IMP
RGD
PMID:7740056 PMID:6445277
RGD:1598524 , RGD:10047091
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
IMP
RGD
PMID:18947822
RGD:6906919
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19109989
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cck
cholecystokinin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2320253
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
G
Comt
catechol-O-methyltransferase
IMP
RGD
PMID:16437585
RGD:2289781
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
ISO
RGD
PMID:1673290
RGD:1358547
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Dbn1
drebrin 1
IEP
levodopainduced; protein:increased expression:striatum:
RGD
PMID:23241013
RGD:10398811
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
G
Ddc
dopa decarboxylase
IEP
associated with Parkinson Disease; protein:decreased expression:striatum (rat)
RGD
PMID:20232137
RGD:5128860
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Drd1
dopamine receptor D1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
G
Drd2
dopamine receptor D2
IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801
RGD:2311579
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Drd3
dopamine receptor D3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20945430
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Egr1
early growth response 1
IEP
RGD
PMID:22153973
RGD:10395307
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17219962
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Gad1
glutamate decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9767399
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gch1
GTP cyclohydrolase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gdnf
glial cell derived neurotrophic factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11168568
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Glul
glutamate-ammonia ligase
IDA
RGD
PMID:6445277
RGD:10047091
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Grk6
G protein-coupled receptor kinase 6
IMP
associated with Parkinson Disease
RGD
PMID:20410529
RGD:5684919
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IMP
associated with Parkinsonian Disorders
RGD
PMID:26997328
RGD:13792768
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Homer1
homer scaffold protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24126708
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
G
Htr1a
5-hydroxytryptamine receptor 1A
IMP
RGD
PMID:21352823
RGD:5683628
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
G
Mapt
microtubule-associated protein tau
treatment
IDA
associated with Parkinsonian Disorders
RGD
PMID:25511986
RGD:13800920
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mtor
mechanistic target of rapamycin kinase
treatment
IMP
associated with Parkinsonian Disorders
RGD
PMID:23938307
RGD:10040953
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Pdyn
prodynorphin
treatment severity
ISO IEP HEP
CTD Direct Evidence: marker/mechanism associated with Parkinsonism associated with Parkinsonism;protein:increased expression:striatum
CTD RGD
PMID:9767399 PMID:21737418 PMID:10869049 PMID:17884291 PMID:21737418
RGD:401900134 , RGD:401851046 , RGD:401850563
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
treatment disease_progression
IEP ISO
mRNA:increased expression:brain:striatum: associated with Parkinsonism associated with Parkinsonism;mRNA:increased expression:striatum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9767399 PMID:20456008 PMID:10869049 PMID:26113400
RGD:10003039 , RGD:401900134 , RGD:401851054
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
treatment
IDA
associated with Parkinsonian Disorders
RGD
PMID:27771532
RGD:13514053
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21115823
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rela
RELA proto-oncogene, NF-kB subunit
IEP
protein:increased expression:nucleus, brain
RGD
PMID:18590723
RGD:2298778
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rgs4
regulator of G-protein signaling 4
treatment
IMP
associated with Parkinsonian Disorders
RGD
PMID:24969021
RGD:13524515
NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068
G
Rgs9
regulator of G-protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18160641 PMID:24663062
NCBI chr10:94,195,265...94,270,892
Ensembl chr10:94,197,054...94,270,892
G
Th
tyrosine hydroxylase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Nos3
nitric oxide synthase 3
treatment
IDA
RGD
PMID:29064425
RGD:13450913
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Abcc2
ATP binding cassette subfamily C member 2
susceptibility no_association
ISO
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) DNA:SNPs:multiple:
RGD
PMID:17502832 PMID:22178260
RGD:14700816 , RGD:14700817
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
IDA
DNA:hypermethylation:promoter
RGD
PMID:23619520
RGD:14700910
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
IDA
RGD
PMID:16140414
RGD:2316848
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Lpar1
lysophosphatidic acid receptor 1
ISO
protein:increased expression:liver (mouse)
RGD
PMID:12201952
RGD:10054288
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Mir22
microRNA 22
ISO
in male; RNA:increased expression:liver:
RGD
PMID:21750200
RGD:14700876
NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
susceptibility
ISO
ClinVar Annotator: match by term: Efavirenz, poor metabolism of CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:15194512 PMID:15622315 PMID:15668854 PMID:15825040 PMID:15864119 PMID:16267764 PMID:16392089 PMID:16495778 PMID:16857630 PMID:17047492 PMID:17235330 PMID:17356468 PMID:17918089 PMID:17968817 PMID:18057928 PMID:18281305 PMID:18503405 PMID:18655316 PMID:18728241 PMID:18784455 PMID:18839779 PMID:19124658 PMID:19218571 PMID:19228205 PMID:19371316 PMID:19433561 PMID:19474465 PMID:19531981 PMID:19659438 PMID:19704172 PMID:19779319 PMID:20338069 PMID:20441246 PMID:20625352 PMID:20639527 PMID:20720517 PMID:20723261 PMID:20841522 PMID:20860463 PMID:20952418 PMID:21393201 PMID:21441248 PMID:21633320 PMID:21715435 PMID:21860339 PMID:22057858 PMID:22111602 PMID:22354160 PMID:22471906 PMID:22481606 PMID:22680342 PMID:22927450 PMID:22950382 PMID:22992668 PMID:23080225 PMID:23172109 PMID:23254426 PMID:23399569 PMID:23418033 PMID:23640958 PMID:23734829 PMID:23763943 PMID:23859571 PMID:23970651 PMID:23982262 PMID:24080498 PMID:24145522 PMID:24217698 PMID:24299220 PMID:24316028 PMID:24517233 PMID:24521642 PMID:24551111 PMID:24831655 PMID:24956253 PMID:25303294 PMID:25501988 PMID:25611810 PMID:25669165 PMID:25831219 PMID:25882300 PMID:25889207 PMID:25974723 PMID:26107645 PMID:26196596 PMID:26348712 PMID:26774523 PMID:26779253 PMID:26831894 PMID:27195527 PMID:27299708 PMID:27655857 PMID:28145050 PMID:28187506 PMID:28492729 PMID:28692529 PMID:28718515 PMID:28816644 PMID:28886044 PMID:28947469 PMID:29624706 PMID:31628422 PMID:32106141 PMID:32209837 More...
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
C3
complement C3
ISO
associated with Leprosy
RGD
PMID:2783924
RGD:7421527
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cfb
complement factor B
ISO
associated with Leprosy
RGD
PMID:2783924
RGD:7421527
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
associated with Behcet Syndrome;DNA:deletion:: (human)
RGD
PMID:22766250
RGD:7794848
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Lta
lymphotoxin alpha
ISO
associated with Sarcoidosis;DNA:polymorphism:intron
RGD
PMID:19225544
RGD:8548773
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
RT1-CE13
RT1 class I, locus CE13
ISO
associated with Inflammatory Bowel Diseases; DNA:polymorphisms:cds:multiple (human)
RGD
PMID:12198697
RGD:7364926
NCBI chr20:3,314,830...3,318,106
G
Tnf
tumor necrosis factor
susceptibility
ISO
associated with Inflammatory Bowel Diseases;DNA:polymorphisms: :-1031T>C(human)
RGD
PMID:12198697
RGD:7364926
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vdr
vitamin D receptor
susceptibility
ISO
associated with Behcet Syndrome;DNA:polymorphism: : rs7975232(human)
RGD
PMID:24880677
RGD:13217417
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Gpt
glutamic--pyruvic transaminase
treatment
IEP
RGD
PMID:28921207
RGD:14975164
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Kdr
kinase insert domain receptor
treatment
ISO
DNA:polymorphism:cds:p.H472Q(human)
RGD
PMID:20630084
RGD:8552374
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP
Associated with incense smoke exposure;mRNA:increased expression:heart (rat)
RGD
PMID:25687613
RGD:401900684
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
IEP
associated with nitrate tolerance Associated with incense smoke exposure;mRNA:increased expression:heart (rat) associated with nitrate tolerance; protein:decreased expression:thoracic aorta (rat)
RGD
PMID:16520233 PMID:25687613 PMID:12688525
RGD:401900296 , RGD:401900684 , RGD:401900656
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
susceptibility
ISO
DNA:SNP: :CYP2B6*6 (516G>T,785A>G) ((human)
RGD
PMID:27289271
RGD:401901173
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Myh7
myosin heavy chain 7
IEP
Associated with incense smoke exposure;mRNA:increased expression:heart (rat)
RGD
PMID:25687613
RGD:401900684
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
G
Nppa
natriuretic peptide A
IEP
Associated with incense smoke exposure;mRNA:increased expression:heart (rat)
RGD
PMID:25687613
RGD:401900684
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
G
Nppb
natriuretic peptide B
IEP
Associated with incense smoke exposure;mRNA:increased expression:heart (rat)
RGD
PMID:25687613
RGD:401900684
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Psmb8
proteasome 20S subunit beta 8
ISO
ClinVar Annotator: match by term: Nodular erythema digital changes
ClinVar
PMID:20159315 PMID:20534754 PMID:21129723 PMID:21953331 PMID:25741868 PMID:26524591 PMID:28492532 More...
NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
G
Cacna1s
calcium voltage-gated channel subunit alpha1 S
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
G
Gatm
glycine amidinotransferase
IMP HEP
RGD
PMID:15462098 PMID:19664912
RGD:329961309 , RGD:329961312
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gc
GC, vitamin D binding protein
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gpx3
glutathione peroxidase 3
treatment
IEP
RGD
PMID:23662110 PMID:27412471 PMID:22115772
RGD:401827919 , RGD:401827925 , RGD:401827924
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Havcr1
hepatitis A virus cellular receptor 1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Mir494
microRNA 494
ISO
RGD
PMID:25854542
RGD:156420140
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
G
Nos2
nitric oxide synthase 2
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Ryr1
ryanodine receptor 1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
S100a1
S100 calcium binding protein A1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
G
S100b
S100 calcium binding protein B
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Tgfb1
transforming growth factor, beta 1
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Vdr
vitamin D receptor
treatment
IEP
RGD
PMID:37244046
RGD:329853759
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Mbp
myelin basic protein
treatment
IEP
RGD
PMID:33166664
RGD:213230154
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
Mog
myelin oligodendrocyte glycoprotein
treatment
IEP
RGD
PMID:33166664
RGD:213230154
NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474
G
Myrf
myelin regulatory factor
treatment
IEP
RGD
PMID:33166664
RGD:213230154
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
G
Plp1
proteolipid protein 1
treatment
IEP
RGD
PMID:33166664
RGD:213230154
NCBI chr X:100,184,039...100,201,035
Ensembl chr X:100,185,767...100,201,032
G
Casp9
caspase 9
IEP
RGD
PMID:25014874
RGD:13782349
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ptger3
prostaglandin E receptor 3
treatment
IMP
RGD
PMID:11991626
RGD:10003093
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
G
Ptger4
prostaglandin E receptor 4
treatment
IMP
RGD
PMID:11991626
RGD:10003093
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Tpmt
thiopurine S-methyltransferase
ISO
OMIM
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
G
Nudt15
nudix hydrolase 15
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Thiopurines, poor metabolism of, 2
OMIM CTD ClinVar
PMID:22992668 PMID:25108385 PMID:25624441 PMID:26033531 PMID:26076924 PMID:26405151 PMID:26503813 PMID:26590936 PMID:26735160 PMID:26878724 PMID:27095468 PMID:27193222 PMID:27416873 PMID:27558924 PMID:27577869 PMID:27604507 PMID:28088792 PMID:28146264 PMID:28418010 PMID:28445187 PMID:28659275 PMID:29702976 PMID:29704867 PMID:29720126 PMID:29867468 PMID:29923122 PMID:29967377 PMID:30035323 PMID:30048756 PMID:30101994 PMID:30728528 PMID:31024313 More...
NCBI chr15:48,707,776...48,713,847
Ensembl chr15:48,709,700...48,747,363
G
Cabp1
calcium binding protein 1
IEP
protein:altered expression:postsynaptic density
RGD
PMID:19224364
RGD:14399959
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:350256 PMID:9380243
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alb
albumin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12239465
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Apcs
amyloid P component, serum
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
G
C1qa
complement C1q A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qc
complement C1q C chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
G
Cav1
caveolin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Celf2
CUGBP, Elav-like family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
G
Cfhr1
complement factor H-related 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr13:51,395,583...51,410,571
Ensembl chr13:51,369,211...51,410,592
G
Cfp
complement factor properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
G
Clu
clusterin
ISO
mRNA:decreased expression:conjunctiva
RGD
PMID:12036968
RGD:8699507
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cops5
COP9 signalosome subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
G
Crp
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11321886
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cul1
cullin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 4:76,551,952...76,625,830
Ensembl chr 4:76,551,983...76,627,980
G
Cul4a
cullin 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
G
Derl1
derlin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
G
Elmo1
engulfment and cell motility 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
G
Ep300
E1A binding protein p300
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Fbxo6
F-box protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
G
Gstm1
glutathione S-transferase mu 1
ISO
RGD
PMID:28689274
RGD:14700974
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9372356
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir18a
microRNA 18a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
G
Nfkbiz
NFKB inhibitor zeta
ISS
MouseDO
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nos2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10620138
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nucb1
nucleobindin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
G
Orm1
orosomucoid 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
G
Parp1
poly (ADP-ribose) polymerase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pml
PML nuclear body scaffold
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
G
Pros1
protein S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Psmc5
proteasome 26S subunit, ATPase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
G
Ptger3
prostaglandin E receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21966456
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
G
Ptgis
prostaglandin I2 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 3:155,928,564...155,964,228
Ensembl chr 3:155,916,412...155,965,451
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbx1
ring-box 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 7:112,976,863...113,001,051
Ensembl chr 7:112,990,835...113,001,051
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0601 (human)
RGD
PMID:8841298
RGD:7483570
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-CE13
RT1 class I, locus CE13
susceptibility
ISO
DNA:polymorphisms:cds:HLA-B*5801 (human, Japanese) DNA:polymorphisms:cds:HLA-B*15:02, HLA-B*40:01, HLA-B*58:02 (human)
RGD
PMID:19018717 PMID:23692434
RGD:7364874 , RGD:7365090
NCBI chr20:3,314,830...3,318,106
G
RT1-CE16
RT1 class I, locus CE16
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hypersensitivity syndrome, carbamazepine-induced, susceptibility to
CTD OMIM ClinVar
PMID:16538176 PMID:21428769 PMID:23588310
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:blister:
RGD
PMID:9852250
RGD:7401184
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vcp
valosin-containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25811541
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
G
Vwf
von Willebrand factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34142820
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
ISO
associated with schizophrenia
RGD
PMID:10889552
RGD:1358545
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Drd3
dopamine receptor D3
ISO
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
G
Sod2
superoxide dismutase 2
ISO
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tpmt
thiopurine S-methyltransferase
ISO ISS
CTD Direct Evidence: marker/mechanism OMIM:610460 ClinVar Annotator: match by term: Thiopurine methyltransferase deficiency
CTD MouseDO ClinVar
PMID:1960624 PMID:7862671 PMID:8561894 PMID:8644731 PMID:9177237 PMID:9246020 PMID:9931345 PMID:9931346 PMID:10208641 PMID:10751626 PMID:15819814 PMID:16476125 PMID:17885628 More...
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all